{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-062226","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.978543+00:00","generated_at":"2026-05-31T20:20:57.229468+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Emmaus Life Sciences appoints Willis Lee as CEO, eliminates interim Co-President role","bullets":["Willis Lee appointed CEO effective July 15, 2024; previously interim Co-President and COO.","Lee continues as Chairman of the Board (since Oct 2023); compensation unchanged.","George Sekulich, former interim Co-President, continues as Chief Commercial and Information Officer.","Move eliminates the interim Co-President structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-062226","json":"https://secwatch.observer/filing/0001213900-24-062226.json","markdown":"https://secwatch.observer/filing/0001213900-24-062226.md","text":"https://secwatch.observer/filing/0001213900-24-062226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390024062226/0001213900-24-062226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390024062226/ea0209587-8k_emmaus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:20:57.229468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"290a7100c9","claim":"Willis Lee was appointed as Chief Executive Officer at Emmaus Life Sciences, Inc..","evidence_excerpt":"On July 15, 2024, the Board of Directors of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) appointed Willis Lee as our Chief Executive Officer and eliminated the former offices of interim Co-President.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390024062226/0001213900-24-062226-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}